Cargando…

Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947601/
https://www.ncbi.nlm.nih.gov/pubmed/27288391
http://dx.doi.org/10.1136/annrheumdis-2013-204016corr1
_version_ 1782443194184630272
collection PubMed
description
format Online
Article
Text
id pubmed-4947601
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49476012016-07-28 Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study Ann Rheum Dis Electronic Pages BMJ Publishing Group 2016-07 /pmc/articles/PMC4947601/ /pubmed/27288391 http://dx.doi.org/10.1136/annrheumdis-2013-204016corr1 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
spellingShingle Electronic Pages
Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
title Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
title_full Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
title_fullStr Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
title_full_unstemmed Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
title_short Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
title_sort correction: discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the honor study
topic Electronic Pages
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947601/
https://www.ncbi.nlm.nih.gov/pubmed/27288391
http://dx.doi.org/10.1136/annrheumdis-2013-204016corr1